Accipio Ix (discontinued)
MaxQ AI, Ltd.
Product specifications |
Information source:
Vendor
Last updated: Jan. 21, 2022 |
General | |
---|---|
Product name | Accipio Ix (discontinued) |
Company | MaxQ AI, Ltd. |
Subspeciality | Neuro |
Modality | CT |
Disease targeted | Intracranial hemorrhage |
Key-features | Per-case detection of ICH |
Suggested use | Before: adapting worklist order |
Data characteristics | |
Population | Stroke and head trauma patients suspicion of intracranial hemorrhage |
Input | Adult non-contrast head CT |
Input format | DICOM |
Output | Triage with notification |
Output format | DICOM Secondary Capture |
Technology | |
Integration | Integration in standard reading environment (PACS), Integration RIS (Radiological Information System), Integration CIS (Clinical Information System), Integration via AI marketplace or distribution platform |
Deployment | Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based, Hybrid solution |
Trigger for analysis | Automatically, right after the image acquisition |
Processing time | |
Certification | |
CE
|
Certified,
Class IIb
, MDD
|
FDA
|
510(k) cleared, Class II |
Market presence | |
On market since | 05-2018 |
Distribution channels | GE, Philips, FujiFilm, IBM, Nuance, Blackford |
Countries present (clinical, non-research use) | |
Paying clinical customers (institutes) | |
Research/test users (institutes) | |
Pricing | |
Pricing model | Pay-per-use, Subscription |
Based on | Number of installations, Number of analyses |
Evidence | |
Peer reviewed papers on performance | |
Non-peer reviewed papers on performance | |
Other relevant papers |